Good Evening Market Enthusiast,
Clear your morning calendar ☀️
At 8:00 AM ET tomorrow, we’re dropping a micro-cap biotech that checks every adrenaline box on our screen:
🌊 Float? Smaller than what some mega-caps churn before the opening bell.
👀 Wall Street
outlook? A trio of analysts are shouting triple-digit upside with a high-side target that implies ~2.5× from recent close.
🔥 Pipeline heat? One already-cleared therapy primed for launch, two more late-stage assets lining up behind it.
🧨 Built-in fuse? A catalyst calendar so tight you can practically hear it tick—commercial debut,
fast-lane regulatory filing, Phase 3 kickoff, all inside 12 months.
Add disciplined cash in the bank, founders who keep tossing their own chips on the table, and a recently cleared compliance cloud—and you’ve got the kind of structural imbalance that turns quiet tickers into scrolling headlines.
Don’t miss this one…
Talk soon,
Max Masters
Co-founder, Market Tips Newsletter